<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37373853</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Diagnostic Usefulness of Spiroergometry and Risk Factors of Long COVID in Patients with Normal Left Ventricular Ejection Fraction.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4160</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12124160</ELocationID><Abstract><AbstractText>The emergence of the Coronavirus Disease 2019 (COVID-19) pandemic has brought forth various clinical manifestations and long-term complications, including a condition known as long COVID. Long COVID refers to a persistent set of symptoms that continue beyond the acute phase of the disease. This study investigated the risk factors and the utility of spiroergometry parameters for diagnosing patients with long COVID symptoms. The 146 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with normal left ventricular ejection fraction and without respiratory diseases were included and divided into two groups: the group demonstrating long COVID symptoms [n = 44] and the group without long COVID symptoms [n = 102]. The clinical examinations, laboratory test results, echocardiography, non-invasive body mass analysis, and spiroergometry were evaluated. ClinicalTrials.gov Identifier: NCT04828629. Patients with long COVID symptoms had significantly higher age [58 (vs.) 44 years; <i>p</i> &lt; 0.0001], metabolic age [53 vs. 45 years; <i>p</i> = 0.02)], left atrial diameter (LA) [37 vs. 35 mm; <i>p</i> = 0.04], left ventricular mass index (LVMI) [83 vs. 74 g/m<sup>2</sup>, <i>p</i> = 0.04], left diastolic filling velocity (A) [69 vs. 64 cm/s, <i>p</i> = 0.01], the ratio of peak velocity of early diastolic transmitral flow to peak velocity of early diastolic mitral annular motion (E/E') [7.35 vs. 6.05; <i>p</i> = 0.01], and a lower ratio of early to late diastolic transmitral flow velocity (E/A) [1.05 vs. 1.31; <i>p</i> = 0.01] compared to the control group. In cardiopulmonary exercise testing (CPET), long COVID patients presented lower forced vital capacity (FVC) [3.6 vs. 4.3 L; <i>p</i> &lt; 0.0001], maximal oxygen consumption measured during incremental exercise indexed per kilogram (VO<sub>2max</sub>) [21 vs. 23 mL/min/kg; <i>p</i> = 0.04], respiratory exchange ratio (RER) [1.0 vs. 1.1; <i>p</i> = 0.04], forced expiratory volume in one second (FEV1) [2.90 vs. 3.25 L; <i>p</i> = 0.04], and a higher ratio of forced expiratory volume in one second to forced vital capacity (FEV1/FVC%) [106 vs. 100%; <i>p</i> = 0.0002]. The laboratory results pointed out that patients with long COVID symptoms also had a lower rate of red blood cells (RBC) [4.4 vs. 4.6 &#xd7; 10<sup>6</sup>/uL; <i>p</i> = 0.01]; a higher level of glucose [92 vs. 90 mg/dL; <i>p</i> = 0.03]; a lower glomerular filtration rate (GFR) estimate by Modification of Diet in Renal Disease (MDRD) [88 vs. 95; <i>p</i> = 0.03]; and a higher level of hypersensitive cardiac Troponin T (hs-cTnT) [6.1 vs. 3.9 pg/mL; <i>p</i> = 0.04]. On the multivariate model, only FEV1/FVC% (OR 6.27, 95% CI: 2.64-14.86; <i>p</i> &lt; 0.001) independently predicted the long COVID symptoms. Using the ROC analysis, the FEV1/FVC% &#x2265; 103 was the most powerful predictor of spiroergometry parameters (0.67 sensitive, 0.71 specific, AUC of 0.73; <i>p</i> &lt; 0.001) in predicting the symptoms of long COVID. Spiroergometry parameters are useful in diagnosing long COVID and differentiating it from cardiovascular disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gryglewska-Wawrzak</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7902-3042</Identifier><AffiliationInfo><Affiliation>Heart Failure Unit, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakowicz</LastName><ForeName>Agata</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5083-2046</Identifier><AffiliationInfo><Affiliation>Department of Medical Biotechnology, Medical University of Lodz, 90-752 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banach</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6690-6874</Identifier><AffiliationInfo><Affiliation>Heart Failure Unit, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Cardiology and Lipidology, Medical University of Lodz, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byty&#xe7;i</LastName><ForeName>Ibadete</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-8996-4257</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Clinical Medicine, Ume&#xe5; University, 901 87 Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Cardiology, University Clinical Centre of Kosova, 10000 Prishtina, Kosovo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bielecka-Dabrowa</LastName><ForeName>Agata</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6666-3999</Identifier><AffiliationInfo><Affiliation>Heart Failure Unit, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Cardiology and Lipidology, Medical University of Lodz, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04828629</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>PMMHRI-BCO.75/2020</GrantID><Agency>Polish Mother's Memorial Hospital Research Institute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">body mass compartments</Keyword><Keyword MajorTopicYN="N">exercise intolerance</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37373853</ArticleId><ArticleId IdType="pmc">PMC10299442</ArticleId><ArticleId IdType="doi">10.3390/jcm12124160</ArticleId><ArticleId IdType="pii">jcm12124160</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu J.T., Leung K., Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet. 2020;395:689&#x2013;697. doi: 10.1016/S0140-6736(20)30260-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30260-9</ArticleId><ArticleId IdType="pmc">PMC7159271</ArticleId><ArticleId IdType="pubmed">32014114</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Coronavirus Disease (COVID-19) Pandemic. 2020.  [(accessed on 8 May 2023)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>Lovato A., de Filippis C., Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19) Am. J. Otolaryngol. 2020;41:102474. doi: 10.1016/j.amjoto.2020.102474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102474</ArticleId><ArticleId IdType="pmc">PMC7128936</ArticleId><ArticleId IdType="pubmed">32278470</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyranoski D. Profile of a killer: The complex biology powering the coronavirus pandemic. Nature. 2020;581:22&#x2013;26. doi: 10.1038/d41586-020-01315-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-01315-7</ArticleId><ArticleId IdType="pubmed">32367025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge X.-Y., Li J.-L., Yang X.-L., Chmura A.A., Zhu G., Epstein J.H., Mazet J.K., Hu B., Zhang W., Peng C., et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503:535&#x2013;538. doi: 10.1038/nature12711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12711</ArticleId><ArticleId IdType="pmc">PMC5389864</ArticleId><ArticleId IdType="pubmed">24172901</ArticleId></ArticleIdList></Reference><Reference><Citation>Bielecka-Dabrowa A., Cichocka-Radwan A., Lewek J., Pawliczak F., Maciejewski M., Banach M. Cardiac manifestations of COVID-19. Rev. Cardiovasc. Med. 2021;22:365&#x2013;371. doi: 10.31083/j.rcm2202043.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm2202043</ArticleId><ArticleId IdType="pubmed">34258904</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher G.F., Oken K.R., Safford R.E. Comprehensive rehabilitation of patients with coronary artery disease. In: Braunwald E., editor. Heart Disease, a Textbook of Cardiovascular Medicine. 6th ed. Saunders; Philadelphia, PA, USA: 2001. pp. 1406&#x2013;1421.</Citation></Reference><Reference><Citation>Gryglewska-Wawrzak K., Sakowicz A., Banach M., Maciejewski M., Bielecka-Dabrowa A. Factors of Persistent Limited Exercise Tolerance in Patients after COVID-19 with Normal Left Ventricular Ejection Fraction. Biomedicines. 2022;10:3257. doi: 10.3390/biomedicines10123257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10123257</ArticleId><ArticleId IdType="pmc">PMC9775927</ArticleId><ArticleId IdType="pubmed">36552013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell C., Rahko P.S., Blauwet L.A., Canaday B., Finstuen J.A., Foster M.C., Horton K., Ogunyankin K.O., Palma R.A., Velazquez E.J. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2018;32:1&#x2013;64. doi: 10.1016/j.echo.2018.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2018.06.004</ArticleId><ArticleId IdType="pubmed">30282592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosaraju A., Goyal A., Grigorova Y. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Left Ventricular Ejection Fraction.</Citation><ArticleIdList><ArticleId IdType="pubmed">29083812</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wei X., Kong L., Liu M., Tang H. Evaluating the left ventricular global systolic function of patients with diabetes mellitus by the real-time three-plane speckle tracking imaging. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = J. Biomed. Eng. 2013;30:513&#x2013;517. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">23865310</ArticleId></ArticleIdList></Reference><Reference><Citation>Tousignant C., Kim H., Papa F., Mazer C.D. Evaluation of TAPSE as a measure of right ventricular output. Can. J. Anaesth. 2012;59:376&#x2013;383. doi: 10.1007/s12630-011-9659-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-011-9659-3</ArticleId><ArticleId IdType="pubmed">22302303</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce R. Spirometry: An essential clinical measurement. Aust. Fam. Physician. 2005;34:535&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">15999163</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes J.M. Basic spirometry testing and interpretation for the primary care provider. Can. J. Respir. Ther. 2018;54:92&#x2013;98. doi: 10.29390/cjrt-2018-017.</Citation><ArticleIdList><ArticleId IdType="doi">10.29390/cjrt-2018-017</ArticleId><ArticleId IdType="pmc">PMC6516140</ArticleId><ArticleId IdType="pubmed">31164790</ArticleId></ArticleIdList></Reference><Reference><Citation>Albouaini K., Egred M., Alahmar A., Wright D.J. Cardiopulmonary exercise testing and its application. Postgrad. Med. J. 2007;83:675&#x2013;682. doi: 10.1136/hrt.2007.121558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2007.121558</ArticleId><ArticleId IdType="pmc">PMC2734442</ArticleId><ArticleId IdType="pubmed">17989266</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinstein J., Sawalha Y., Medvedofsky D.A., Ahmad S., Hofmeyer M., Rodrigo M., Kadakkal A., Barnett C., Kalantari S., Talati I., et al. VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device: A fresh look at cardiopulmonary stress testing for prognostication. J. Artif. Organs. 2021;24:425&#x2013;432. doi: 10.1007/s10047-021-01261-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10047-021-01261-9</ArticleId><ArticleId IdType="pubmed">33792816</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;hm A., Heitmann B.L. The use of bioelectrical impedance analysis for body composition in epidemiological studies. Eur. J. Clin. Nutr. 2013;67:S79&#x2013;S85. doi: 10.1038/ejcn.2012.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2012.168</ArticleId><ArticleId IdType="pubmed">23299875</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaafar Z.A., Kreidieh D., Itani L., Tannir H., El Masri D., El Ghoch M. Cross-validation of prediction equations for estimating the body fat percentage in adults with obesity. Clin. Nutr. ESPEN. 2021;41:346&#x2013;350. doi: 10.1016/j.clnesp.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2020.11.003</ArticleId><ArticleId IdType="pubmed">33487288</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C., Tudoran M., Pop G.N., Giurgi-Oncu C., Cut T.G., Lazureanu V.E., Oancea C., Parv F., Ciocarlie T., Bende F. Associations between the Severity of the Post-Acute COVID-19 Syndrome and Echocardiographic Abnormalities in Previously Healthy Outpatients Following Infection with SARS-CoV-2. Biology. 2021;10:469. doi: 10.3390/biology10060469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10060469</ArticleId><ArticleId IdType="pmc">PMC8226755</ArticleId><ArticleId IdType="pubmed">34073342</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G., Goldoni M., Cavalli C., Perrino F., Tagliaferri S., Frizzelli A., Mori P.A., Majori M., Aiello M., Sverzellati N., et al. Long-Term Cardiac Sequelae in Patients Referred into a Diagnostic Post-COVID-19 Pathway: The Different Impacts on the Right and Left Ventricles. Diagnostics. 2021;11:2059. doi: 10.3390/diagnostics11112059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11112059</ArticleId><ArticleId IdType="pmc">PMC8623572</ArticleId><ArticleId IdType="pubmed">34829406</ArticleId></ArticleIdList></Reference><Reference><Citation>Messika-Zeitoun D., Bellamy M., Avierinos J.F., Breen J., Eusemann C., Rossi A., Behrenbeck T., Scott C., Tajik J., Enriquez-Sarano M. Left atrial remodelling in mitral regurgitation- methodologic approach, physiological determinants, and outcome implications: A prospective quantitative Doppler-echocardiographic and electron beamcomputed tomographic study. Eur. Heart J. 2007;28:1773&#x2013;1781. doi: 10.1093/eurheartj/ehm199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehm199</ArticleId><ArticleId IdType="pubmed">17562673</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin E.J., D&#x2019;Agostino R.B., Belanger A.J., Wolf P.A., Levy D. Left Atrial Size and the Risk of Stroke and Death. The Framingham heart study. Circulation. 1995;92:835&#x2013;841. doi: 10.1161/01.CIR.92.4.835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.4.835</ArticleId><ArticleId IdType="pubmed">7641364</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli A., Misuraca C., Bianchi A., Borsa N., Limonta S., Maggiolini S., Bonardi D.R., Corsonello A., Di Rosa M., Soraci L., et al. Long-term changes in pulmonary function among patients surviving to COVID-19 pneumonia. Infection. 2021;50:1019&#x2013;1022. doi: 10.1007/s15010-021-01718-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01718-2</ArticleId><ArticleId IdType="pmc">PMC8517554</ArticleId><ArticleId IdType="pubmed">34652626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., Trivieri M.G., Contreras J.P., Natelson B.H. Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post-Coronavirus Disease. JACC Heart Fail. 2021;9:927&#x2013;937. doi: 10.1016/j.jchf.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Sun K., Tahir P., Peluso M.J., Deeks S.G., Aras M.A., Grandis D.J., Long C.S., Beatty A., Hsue P.Y. Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis. JAMA Netw. Open. 2022;5:e2236057. doi: 10.1001/jamanetworkopen.2022.36057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.36057</ArticleId><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kub&#xe1;nkov&#xe1; M., Hohberger B., Hoffmanns J., F&#xfc;rst J., Herrmann M., Guck J., Kr&#xe4;ter M. Physical phenotype of blood cells is altered in COVID-19. Biophys. J. 2021;120:2838&#x2013;2847. doi: 10.1016/j.bpj.2021.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.025</ArticleId><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Xu E., Al-Aly Z. Kidney Outcomes in Long COVID. J. Am. Soc. Nephrol. 2021;32:2851&#x2013;2862. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode B., Garrett V., Messler J., McFarland R., Crowe J., Booth R., Klonoff D.C. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J. Diabetes Sci. Technol. 2020;14:813&#x2013;821. doi: 10.1177/1932296820924469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296820924469</ArticleId><ArticleId IdType="pmc">PMC7673150</ArticleId><ArticleId IdType="pubmed">32389027</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., Alpert J.S., White H.D., Accf, Aha, Thygesen T.F.M.C.K., Vahanian C.A., Reviewers D. Universal Definition of Myocardial Infarction. Circulation. 2007;116:2634&#x2013;2653. doi: 10.1161/CIRCULATIONAHA.107.187397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.187397</ArticleId><ArticleId IdType="pubmed">17951284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wibowo A., Pranata R., Akbar M.R., Purnomowati A., Martha J.W. Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression. Int. J. Infect. Dis. 2021;105:312&#x2013;318. doi: 10.1016/j.ijid.2021.02.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.02.113</ArticleId><ArticleId IdType="pmc">PMC7923942</ArticleId><ArticleId IdType="pubmed">33667694</ArticleId></ArticleIdList></Reference><Reference><Citation>Daitch V., Yelin D., Awwad M., Guaraldi G., Mili&#x107; J., Mussini C., Falcone M., Tiseo G., Carrozzi L., Pistelli F., et al. Characteristics of long-COVID among older adults: A cross-sectional study. Int. J. Infect. Dis. 2022;125:287&#x2013;293. doi: 10.1016/j.ijid.2022.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.09.035</ArticleId><ArticleId IdType="pubmed">36191820</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Madlock-Brown C., Baratta J.M., Bhatia A., Davis H., Girvin A., Hill E., Kelly E., Kostka K., Loomba J., et al. Coding long COVID: Characterizing a new disease through an ICD-10 lens. Int. J. Infect. Dis. 2023;21:58. doi: 10.1186/s12916-023-02737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo C., Visco V., Gambardella J., Ferruzzi G.J., Rispoli A., Rusciano M.R., Toni A.L., Virtuoso N., Carrizzo A., Di Pietro P., et al. Cardiovascular Implications of microRNAs in Coronavirus Disease 2019. J. Pharmacol. Exp. Ther. 2023;384:102&#x2013;108. doi: 10.1124/jpet.122.001210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001210</ArticleId><ArticleId IdType="pubmed">35779946</ArticleId></ArticleIdList></Reference><Reference><Citation>Gra&#xf1;a C., Ghosn L., Evrenoglou T., Jarde A., Minozzi S., Bergman H., Buckley B.S., Probyn K., Villanueva G., Henschke N., et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst. Rev. 2022;12:CD015477. doi: 10.1002/14651858.cd015477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.cd015477</ArticleId><ArticleId IdType="pmc">PMC9726273</ArticleId><ArticleId IdType="pubmed">36473651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed K., Rzymski P., Islam M.S., Makuku R., Mushtaq A., Khan A., Ivanovska M., Makka S.A., Hashem F., Marquez L., et al. COVID-19 vaccinations: The unknowns, challenges, and hopes. J. Med. Virol. 2022;94:1336&#x2013;1349. doi: 10.1002/jmv.27487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27487</ArticleId><ArticleId IdType="pmc">PMC9015467</ArticleId><ArticleId IdType="pubmed">34845731</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>